I tu przychodzi genialna myl Eli Lilly: co gdybymy oprcz obniania apetytu (GLP-1, GIP) jednoczenie zwikszali take wydatek energetyczny (glukagon)
,
West S, Scragg J, Aveyard P, et al
Retatrutide does not have FDA approval as of 2025
Starting in 2022, increased demand led to shortages of semaglutide injections sold by Novo Nordisk under the brand names Ozempic and Wegovy, as well as tirzepatide injections Zepbound and Mounjaro from competitor Eli Lilly
154,155,156 Furthermore, in the process of intestinal microbial reorganization, as the F/B ratio changes, the infiltration of inflammatory cells gradually decreases, and the structure and function of the intestinal barrier are gradually restored